Clinical Trial Search

Primary: Time to Event Analysis: Number of Patients Who Experienced the First Cardiovascular Hospitalization Within 2 Years Post-implant — 43; 40 number of participants — p=0.72

Primary: Safety — 43; 39 adverse events

Primary: Number of Intervention — 1.9; 7.5 Number of intervention — p=0.05

Primary: The Percent of Sensitized Patients Treated With PRA Reduction Pharmacological Therapy, Including Cytogam, Who Become Cross-match Compatible With Potential Living Donor…

Primary: Change in Total Score on the BDD-Y-BOCS Scale — -12.27; -9.53 units on a scale

Primary: HAMD Rating Scores — 16.86; 10.71; 9.81; 7.33 Units on a scale

Primary: Percentage of Participants Achieving Confirmed Complete Response (CR) According to International Workshop on Chronic Lymphocytic Leukemia (IWCLL) 2008 Guidelines in the…

Primary: Bone Mineral Density (BMD): Examine the Pattern and Effect of BMD Changes at Hip and Spine Measured by DXA Every 6 Months. — 0.85; 0.84; 0.91 percent change

Primary: Change From Baseline to Week 15 in Mean Pain Diary Score — -1.60; -0.94 Units on a scale — p=0.121

Primary: MMSE at Baseline and at Three (3) Months. — 18.2; 2.2 units on a scale — p=.01

Primary: Percentage of Patients With Normal Body Temperature — 4; 1; 15; 15 Percentage of participants — p=0.05

Primary: Present the Percentage of Participants With an Excellent Ease of Intubation Rating — 91; 17 % reported as excellent

Primary: Percentage of Participants Assessed as Very Much Improved or Much Improved Based on the Clinical Global Impression-Improvement (CGI-I) Scale — 54.4; 33.1 percentage of…

Primary: Change From Baseline in Patient-reported Treatment Satisfaction — 19.57; 5.83 score on a scale

Primary: To Determine if an Adjusted-dose of Fondaparinux 2.5 mg Subcutaneously (SQ) q48 hr in Critically Ill Patients With Renal Failure Will Achieve Peak and Trough Levels…